Literature DB >> 3398544

Acute liver dysfunction after modified Fontan operation for complex cardiac lesions. Analysis of the contributing factors and its relation to the early prognosis.

H Matsuda1, E Covino, H Hirose, S Nakano, H Kishimoto, Y Miyamoto, K Nishigaki, H Takano, S Ohtake, S Sakaki.   

Abstract

Acute liver dysfunction was analyzed in 15 patients who received a modified Fontan operation for single ventricle in nine (atrial isomerism, seven) and tricuspid or mitral atresia in six. Nine patients had elevation of serum glutamic-pyruvic transaminase levels above 1000 U/L during the first week. As an analysis of postoperative liver function during the first week, the highest values of serum glutamic-pyruvic transaminase and total bilirubin and the lowest prothrombin time were scored from 0 to 4 within each parameter, and totaled to give a liver dysfunction score. The liver dysfunction score was 0 to 2 (no or trivial injury) in five patients, 3 to 5 (mild) in two, and 6 to 11 (moderate or severe) in eight (53.3%). The group operated on for single ventricle had a higher incidence (67%) of a liver dysfunction score of 6 or higher than the other group (33%). A multivariate analysis for the prediction of the liver dysfunction score mainly from early postoperative hemodynamics showed the highest correlation with cardiac index, followed by urine output, systolic arterial pressure, and central venous pressure. One patient required plasmapheresis. Four died early (less than 1 month); three of these had a liver dysfunction score of 6 or higher. Those with scores of 6 or above had higher serum glutamic-pyruvic transaminase levels at 1 month after operation than those with scores less than 5. In three patients (single ventricle), hepatic venous oxygen saturation was monitored and showed a marked decrease to below 20% with subsequent acute liver dysfunction. These results indicate that acute liver dysfunction appears to occur in patients with complex lesions after a modified Fontan operation from possible hepatic hypoperfusion and that low cardiac output may be more crucial than high central venous pressure alone.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3398544

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  5 in total

1.  Functional deterioration of the liver by elevated inferior vena cava pressure: a proposed upper safety limit of pressure for maintaining liver viability in dogs.

Authors:  H Higashiyama; M Yamaguchi; K Kumada; H Sasaki; T Yamaguchi; K Ozawa
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

2.  Hepatic adenomatosis in a 7-year-old child treated earlier with a Fontan procedure.

Authors:  Kadir Babaoglu; Fatih Köksal Binnetoglu; Ayşen Aydoğan; Gürkan Altun; Yeşim Gürbüz; Nagihan Inan; Funda Corapçioğlu
Journal:  Pediatr Cardiol       Date:  2010-03-04       Impact factor: 1.655

3.  Abnormalities in liver function and coagulation profile following the Fontan procedure.

Authors:  R C van Nieuwenhuizen; M Peters; L J Lubbers; M D Trip; J G Tijssen; B J Mulder
Journal:  Heart       Date:  1999-07       Impact factor: 5.994

Review 4.  Heart transplantation for adults with congenital heart disease: current status and future prospects.

Authors:  Hikaru Matsuda; Hajime Ichikawa; Takayoshi Ueno; Yoshiki Sawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-04-24

5.  Prediction of outcome in patients with liver dysfunction after left ventricular assist device implantation.

Authors:  Hiroyuki Nishi; Koichi Toda; Shigeru Miyagawa; Yasushi Yoshikawa; Satsuki Fukushima; Daisuke Yoshioka; Tetsuya Saito; Shunsuke Saito; Taichi Sakaguchi; Takayoshi Ueno; Toru Kuratani; Yoshiki Sawa
Journal:  J Artif Organs       Date:  2013-08-29       Impact factor: 1.731

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.